U.S. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023
About This Report
This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as ’s proprietary data files was conducted.
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
(continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
IX. USA: Market Size, Growth and Major Suppliers
Sales and Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
(continued)
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac
- Wako
List Of Tables
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A.
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chancroid Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Chlamydia Diagnostics Sales by Major Supplier
U.S.A.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.S. Hemostasis Analyzers Reagents Chromogenic Immunodiagnostic
2024 U.S. Hemostasis Analyzers and Reagents--Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts for Hospitals, Commercial/Private Labs and POC Locations--2023 Competitive Shares and Growth Strategies, Latest Technologies and
USD 2500 View ReportU.S. Coagulation Testing Shares Competitive
2024 U.S. Coagulation Testing Market Shares--Competitive Analysis of Leading and Emerging Market Players This new report provides coagulation testing market shares.The report analyzes current and emerging suppliers of coagulation testing
USD 950 View ReportU.K. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023
About This ReportThis new 280-page report presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,
USD 1950 View ReportSpain 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023
About This ReportThis new 280-page report presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,
USD 1950 View ReportFill The Form For Sample Request